CRNA — Circio Holding ASA Share News
0.000.00%
Last trade - 00:00- NOK2.89bn
- NOK2.36bn
Brief: Circio Raises NOK 10.7 Mln In Upsized Offering From Shareholders
Brief: Circio Requests Funding Under Financing Commitment From Atlas
Brief: Circio Collaborates With Certest
Brief: Circio Holding H1 Total Operating Revenue Loss Down At Nok 22.9 Mln
Brief: Circio Requests Bridge Financing From Atlas
Brief: Circio To Raise Up To About NOK 52 Mln In Rights Issue
Brief: Circio: In Vivo Proof-Of-Concept For Circvec Circular RNA Platform Technology
Brief: Circio To Raise Around NOK 50-60 Million In Q2 2024
Brief: Circio Ends TG01 Cancer Vaccine License Option Agreement
Brief: Circio Holding's Partner IOVaxis Therapeutics Exercises Option For Exclusive License
Brief: Circio Holding Says Atlas Requests Conversion Of Convertible Bonds
Brief: Circio Receives Waiver Of EUR 6.2 Million In Loans From Business Finland
Brief: Circio Announces Outcome Of EU Patent Proceeding
Brief: Circio To Test Combination Of TG01 Vaccination With Daratumumab And Nivolumab
Brief: Circio To Close Unit In Finland, Reduce BoD
Brief: Circio To Collaborate With Neoregen Biotech
Brief: Circio Holding H1 Operating Loss Widens To NOK 72.5 Million
Brief: Circio Holding ASA Says Atlas Requested Conversion Of Convertible Bonds
Brief: Targovax To Rebrand As Circio